首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷分子呈像/呈影劑

市場調查報告書

商品編碼

1623451

全球造影劑市場：區域、範圍和預測

Global Contrast Media Market by Type, By Application, By End-User, By Geographic Scope and Forecast

出版日期: 2024年10月22日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

造影劑的全球市場規模及預測

2024 年全球造影劑市值為 55.4 億美元，預計到 2031 年將達到 68 億美元，2024 年至 2031 年的複合年增長率為 2.59%。造影劑，也稱為造影介質，是醫學影像技術中用來增強身體內部結構可見度的物質。該市場服務於各種醫療保健機構，包括醫院、診斷中心和門診手術中心，並為各種影像方式提供解決方案，包括 X 光/CT、MRI 和超音波。

造影劑市場的未來將受到慢性病盛行率不斷上升、影像技術的進步、微創手術需求不斷增長以及全球醫療支出不斷上升的影響。

全球造影劑市場動態

影響全球造影劑市場的關鍵市場動態

主要市場驅動因子

慢性病發生率不斷上升：

全球慢性病（尤其是心血管疾病和癌症）的增加大大增加了對診斷影像的需求。這種趨勢導致對造影劑的依賴性增加，而造影劑對於提高醫學影像的可見性和準確性以及最終改善患者的治療效果至關重要。

技術進步：

診斷影像技術的最新進展正在徹底改變診斷實踐。開發安全性更高、影像能力更強的新型造影劑對市場發展起著關鍵作用。這些進步使得診斷更加準確，並有利於醫療保健環境中更好的治療計劃和患者管理。

老年人口不斷增加：

日益增長的老年人口特別容易患上各種需要先進影像診斷的疾病。老年人通常需要更頻繁的醫療評估，對可靠的診斷影像解決方案的需求增加，從而推動了對造影劑的需求。這一趨勢凸顯了為老年人制定量身定制的醫療保健策略的重要性。

增加醫療支出：

已開發國家和發展中國家醫療保健支出的增加為引進先進的影像技術和卓越的造影劑鋪平了道路。這些財政支出將支持改進技術，使醫療專業人員能夠提供準確的診斷和有效的治療，最終有利於患者護理和治療結果。

主要問題

副作用與過敏反應：

造影劑相關的潛在副作用和過敏反應，尤其是對腎功能不全患者的擔憂，對市場成長構成了課題。儘管正在開發更安全的藥物，但這些風險仍然是廣泛使用的障礙，需要仔細的患者篩檢和監測。

成本高：

造影劑的成本很高，特別是對於先進的影像方式而言，這可能會限制其在資源受限的醫療保健環境中的採用。雖然這些造影劑可以提高診斷的準確性，但其高昂的價格可能會讓預算有限的小型診所和醫療機構難以負擔。

嚴格的監理要求：

圍繞成像媒體產品的嚴格審批流程和規定可能會延遲市場進入並增加製造商的開發成本。這些措施雖然確保了產品的安全性和有效性，但也減緩了創新，並為試圖在市場上競爭的中小企業設置了障礙。

缺乏熟練的放射科醫師：

全球缺乏經過培訓的放射科醫生和技術人員來管理造影劑和解釋清晰影像，這對市場擴張構成了重大課題。儘管正在努力增加培訓項目，但缺乏專業知識仍然限制了各個地區對比技術的充分利用。

主要趨勢：

器官特異性造影劑的開發：

開發用於特定器官和組織成像的專用造影劑的趨勢日益增長，從而可以實現更有針對性和更有效的診斷。

增加微泡造影劑的使用：

微泡造影劑在超音波影像中的應用越來越廣泛，特別是在心臟病學和放射學應用中，因為它們可以在不使用電離輻射的情況下提高影像品質。

轉向病人友善配方：

為了最大限度地降低患者不適和副作用的風險，造影劑製造商正在努力開發造影劑，重點是提高安全性、降低滲透壓和提高耐受性。

人工智慧整合：

人工智慧和機器學習越來越多地被納入成像工作流程中，以改善影像品質、減少對比劑劑量並提高診斷準確性。

The Global Contrast Media Market was valued at USD 5.54 Billion in 2024 and is projected to reach USD 6.8 Billion by 2031 growing at a CAGR of 2.59% from 2024 to 2031. Contrast media, also known as contrast agents, are substances used to enhance the visibility of internal body structures in medical imaging techniques. The market serves various healthcare settings, including hospitals, diagnostic centers and ambulatory surgical centers, offering solutions for different imaging modalities such as X-ray/CT, MRI and ultrasound.

The future of the contrast media market is shaped by increasing prevalence of chronic diseases, technological advancements in imaging techniques, growing demand for minimally invasive procedures and rising healthcare expenditure globally.

Global Contrast Media Market Dynamics

The key market dynamics that are shaping the global contrast media market include:

Key Market Drivers:

Rising Prevalence of Chronic Diseases:

The global rise in chronic diseases, notably cardiovascular disorders and cancer, is significantly increasing the demand for diagnostic imaging procedures. This trend leads to a greater reliance on contrast media, essential for enhancing the visibility and accuracy of medical imaging, ultimately improving patient outcomes.

Technological Advancements:

Recent innovations in imaging technologies are revolutionizing diagnostic practices. The development of novel contrast agents, which feature improved safety profiles and enhanced imaging capabilities, plays a crucial role in market growth. These advancements ensure more precise diagnostics, facilitating better treatment planning and patient management in healthcare settings.

Growing Geriatric Population:

The expanding elderly population is particularly vulnerable to various diseases that necessitate advanced diagnostic imaging. As older adults typically require more frequent medical assessments, the increasing need for reliable imaging solutions drives the demand for contrast media. This trend underscores the importance of tailored healthcare strategies for seniors.

Increasing Healthcare Expenditure:

Rising healthcare expenditures in both developed and developing nations are paving the way for the adoption of advanced imaging techniques and superior contrast agents. This financial commitment supports technological upgrades, ensuring healthcare providers can deliver accurate diagnoses and effective treatments, ultimately benefiting patient care and outcomes.

Key Challenges:

Side Effects and Allergic Reactions:

Concerns about potential side effects and allergic reactions related to contrast media, especially in patients with renal impairment, present challenges for market growth. While advancements are being made to develop safer agents, these risks still hinder broader adoption and necessitate careful patient screening and monitoring.

High Costs:

The significant costs associated with contrast agents, particularly for advanced imaging modalities, can limit their adoption in resource-constrained healthcare settings. Though these agents offer improved diagnostic accuracy, their high price tags may be prohibitive for smaller clinics and healthcare facilities with limited budgets.

Stringent Regulatory Requirements:

The rigorous approval processes and strict regulations surrounding contrast media products can delay market entry and increase development costs for manufacturers. While these measures ensure product safety and efficacy, they also slow down innovation and raise barriers for smaller companies trying to compete in the market.

Shortage of Skilled Radiologists:

The global shortage of trained radiologists and technicians capable of administering contrast media and interpreting enhanced images poses a significant challenge to market expansion. While efforts are being made to increase training programs, the lack of expertise continues to limit the full utilization of contrast media technologies in various regions.

Key Trends:

Development of Organ-Specific Contrast Agents:

There is a growing trend towards the development of contrast media specifically designed for imaging particular organs or tissue types, allowing for more targeted and efficient diagnostic procedures.

Increasing Use of Microbubble Contrast Agents:

The adoption of microbubble contrast agents for ultrasound imaging is rising, particularly in cardiology and radiology applications, due to their ability to enhance image quality without ionizing radiation.

Shift Towards Patient-Friendly Formulations:

Manufacturers are focusing on developing contrast media with improved safety profiles, reduced osmolality and better tolerability to minimize patient discomfort and risk of adverse reactions.

Integration of Artificial Intelligence:

AI and machine learning are increasingly being incorporated into contrast-enhanced imaging workflows to improve image quality, reduce contrast media dose and enhance diagnostic accuracy.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Contrast Media Market Regional Analysis

Here is a more detailed regional analysis of the global contrast media market:

North America:

According to Verified Market Research, North America is expected to dominate the Global contrast media market.

North America is expected to hold a significant share in the Global contrast media market due to its advanced healthcare infrastructure, high adoption rate of medical imaging technologies and presence of key market players.

The United States is a major contributor to market growth, driven by the high prevalence of chronic diseases and substantial healthcare spending.

The region's focus on early disease detection and preventive healthcare is driving the demand for diagnostic imaging procedures and, consequently, contrast media.

Canada's universal healthcare system and increasing investments in healthcare infrastructure are also contributing to the expansion of the contrast media market in the region.

Europe:

According to Verified Market Research, Europe is the fastest growing region in Global contrast media market.

Europe represents a substantial market for contrast media, driven by the region's aging population and well-established healthcare systems.

Countries like Germany, France and the UK are key contributors to market growth, with their emphasis on advanced medical imaging technologies and high-quality patient care.

The region's strong focus on research and development in medical imaging is fostering innovations in contrast media formulations and applications.

There is a growing trend towards the use of macrocyclic gadolinium-based contrast agents in Europe due to their improved safety profile.

Global Contrast Media Market: Segmentation Analysis

The Global Contrast Media Market is segmented on the basis of Type, Application, End-User and Geography.

Global Contrast Media Market, by Type

Iodinated Contrast Media

Gadolinium-based Contrast Media

Microbubble Contrast Media

Based on Type, the Global Contrast Media Market is divided into Iodinated Contrast Media, Gadolinium-based Contrast Media and Microbubble Contrast Media segments. The Iodinated Contrast Media segment currently dominates the market due to its widespread use in X-ray and CT imaging procedures, which are among the most common diagnostic imaging modalities. These agents offer excellent visualization of blood vessels and organs. The Gadolinium-based Contrast Media segment is expected to show significant growth during the forecast period, driven by the increasing adoption of MRI procedures and the development of novel, safer gadolinium-based agents.

Global Contrast Media Market, by Application

X-ray/CT

MRI

Ultrasound

Based on Application, the Global Contrast Media Market is categorized into X-ray/CT, MRI and Ultrasound segments. The X-ray/CT segment currently leads the market due to the high volume of X-ray and CT procedures performed globally and the essential role of contrast media in enhancing image quality for these modalities. However, the MRI segment is expected to show rapid growth, driven by the increasing use of MRI for detailed soft tissue imaging and the development of advanced gadolinium-based contrast agents.

Global Contrast Media Market, by End-User

Hospitals

Diagnostic Centers

Ambulatory Surgical Centers

Based on End-User, the Global Contrast Media Market is segmented into Hospitals, Diagnostic Centers and Ambulatory Surgical Centers. The Hospitals segment currently dominates the market due to the high volume of diagnostic imaging procedures performed in hospital settings and the availability of advanced imaging equipment. However, the Diagnostic Centers segment is expected to show the fastest growth during the forecast period, driven by the increasing trend towards outpatient imaging services and the growing number of standalone diagnostic facilities.

Global Contrast Media Market, by Geography

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Based on Geography, the Global Contrast Media Market is divided into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America leads the market, driven by advanced healthcare infrastructure, high healthcare expenditure and early adoption of new imaging technologies. Europe follows closely, with a strong focus on research and development in medical imaging. Asia-Pacific is the fastest-growing region, fueled by improving healthcare access, rising prevalence of chronic diseases and increasing investments in healthcare infrastructure.

Key Players

The Global Contrast Media Market study report will provide valuable insight with an emphasis on the global market. The major players in the Contrast Media Market include

GE Healthcare, Bayer AG, Bracco Imaging S.p.A., Guerbet Group, Lantheus Medical Imaging, Inc., Nano Therapeutics Pvt. Ltd., Nemoto Kyorindo Co., Ltd., Sanochemia Pharmazeutika AG, Taejoon Pharm Co., Ltd. and Unijules Life Sciences Ltd.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above- mentioned players globally.

Contrast Media Market Recent Developments

In April 2024, GE Healthcare launched a new AI-powered contrast media injection system designed to optimize contrast dose and timing for personalized imaging protocols, aiming to improve image quality while reducing the risk of contrast-induced nephropathy.

In August 2024, Bayer AG announced the successful completion of a Phase III clinical trial for a novel gadolinium-based contrast agent with improved relaxivity and safety profile, potentially offering enhanced MRI imaging capabilities for neurological applications.

1 INTRODUCTION OF GLOBAL CONTRAST MEDIA MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CONTRAST MEDIA MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL CONTRAST MEDIA MARKET, BY TYPE

5.1 Overview
5.2 Microbubble Contrast Media
5.3 Iodinated Contrast Media
5.4 Gadolinium-based Contrast Media
5.5 Barium-based Contrast Media

6 GLOBAL CONTRAST MEDIA MARKET, BY APPLICATION

6.1 Overview
6.2 Radiology
6.3 Interventional Radiology
6.4 Interventional Cardiology

7 GLOBAL CONTRAST MEDIA MARKET, BY MODALITY

7.1 Overview
7.2 X-ray/Computed Tomography (CT)
7.3 Ultrasound
7.4 Magnetic Resonance Imaging (MRI)

8 GLOBAL CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION

8.1 Overview
8.2 Oral
8.3 Intravascular
8.4 Rectal
8.5 Other Routes

9 GLOBAL CONTRAST MEDIA MARKET, BY INDICATION

9.1 Overview
9.2 Cardiovascular Disorders
9.3 Cancer
9.4 Gastrointestinal Disorders
9.5 Others

10 GLOBAL CONTRAST MEDIA MARKET, BY GEOGRAPHY

10.1 Overview
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 U.K.
- 10.3.3 France
- 10.3.4 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Rest of Asia Pacific
10.5 Rest of the World
- 10.5.1 Latin America
- 10.5.2 Middle East

11 GLOBAL CONTRAST MEDIA MARKET COMPETITIVE LANDSCAPE

11.1 Overview
11.2 Company Market Ranking
11.3 Key Development Strategies

12 COMPANY PROFILES

12.1 GE Healthcare
- 12.1.1 Overview
- 12.1.2 Financial Performance
- 12.1.3 Product Outlook
- 12.1.4 Key Developments
12.2 Guerbet LLC
- 12.2.1 Overview
- 12.2.2 Financial Performance
- 12.2.3 Product Outlook
- 12.2.4 Key Developments
12.3 Bayer AG
- 12.3.1 Overview
- 12.3.2 Financial Performance
- 12.3.3 Product Outlook
- 12.3.4 Key Developments
12.4 Bracco Diagnostics Inc.
- 12.4.1 Overview
- 12.4.2 Financial Performance
- 12.4.3 Product Outlook
- 12.4.4 Key Developments
12.5 Lantheus Medical Imaging, Inc.
- 12.5.1 Overview
- 12.5.2 Financial Performance
- 12.5.3 Product Outlook
- 12.5.4 Key Developments
12.6 Daiichi Sankyo Co. Ltd,
- 12.6.1 Overview
- 12.6.2 Financial Performance
- 12.6.3 Product Outlook
- 12.6.4 Key Developments
12.7 Fuji Pharma Co., Ltd
- 12.7.1 Overview
- 12.7.2 Financial Performance
- 12.7.3 Product Outlook
- 12.7.4 Key Developments